Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria
This study has been completed.
Study NCT01594931   Information provided by Medicines for Malaria Venture

First Received on May 7, 2012.   Last Updated on May 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plasmodium Falciparum Malaria
Additional conditions recognized in this trial
Malaria
Malaria, Falciparum
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
pyronaridine/artesunate
Additional drug interventions recognized in this trial
Artesunate
Pyronaridine
More general drug interventions related to this trial
Amebicides
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Medicines for Malaria Venture
Shin Poong Pharmaceutical Co. Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services